Trump executive order backs change to Medicare negotiation pushed by drug industry

A new executive order signed Tuesday by President Trump directs Congress to change a key provision of the law allowing Medicare drug price negotiations, a move that would fix one of the drug industry’s biggest complaints.  The order applies to what the industry calls the Inflation Reduction Act’s “pill penalty,” where small molecule drugs — typically…



Source link